Our lab, as a contributor to EPLIN research for over a decade, has demonstrated downregulation of EPLIN in multiple tumour tissues, its association with cellular function and clinical significance [2,44,45,46,47,51]. This evidence concerns the gene LIMA1 and neoplasm.